Literature DB >> 14641135

The development of integrated haematopathology laboratories: a new approach to the diagnosis of leukaemia and lymphoma.

S J Richards1, A S Jack.   

Abstract

The diagnosis and monitoring of leukaemia and lymphoma requires the effective integration of a wide range of diagnostic techniques and expertise. The need to develop this type of service that crosses traditional boundaries of laboratory specialities is being recommended in national guidance. The Haematological Malignancy Diagnostic Service based within the Leeds Teaching Hospitals NHS Trust was established in 1993 to provide specialist laboratory services for the diagnosis of haematological malignancy for Yorkshire and Humberside in the UK. The department uses a wide range of methodologies including morphology, immunocytochemistry, flow cytometry and molecular genetics [fluorescent in situ hybridization (FISH) and polymerase chain reaction (PCR)] in a systematic and co-ordinated way. We describe how the department was established, its current working practices and highlight the advantages of an integrated laboratory for diagnosis of tumours of the haematopoietic system.

Entities:  

Mesh:

Year:  2003        PMID: 14641135     DOI: 10.1046/j.0141-9854.2003.00559.x

Source DB:  PubMed          Journal:  Clin Lab Haematol        ISSN: 0141-9854


  3 in total

1.  Evolution of lymphoma staging and response evaluation: current limitations and future directions.

Authors:  Joel Cunningham; Sunil Iyengar; Bhupinder Sharma
Journal:  Nat Rev Clin Oncol       Date:  2017-06-13       Impact factor: 66.675

2.  Postal survey of physicians and laboratories: practices and perceptions of molecular oncology testing.

Authors:  Fiona A Miller; Paul Krueger; Robert J Christensen; Catherine Ahern; Ronald F Carter; Suzanne Kamel-Reid
Journal:  BMC Health Serv Res       Date:  2009-07-30       Impact factor: 2.655

3.  Risk of mature B-cell neoplasms and precursor conditions after joint replacement: A report from the Haematological Malignancy Research Network.

Authors:  Eleanor Kane; Daniel Painter; Alexandra Smith; Maxine Lamb; Steven E Oliver; Russell Patmore; Eve Roman
Journal:  Int J Cancer       Date:  2019-11-23       Impact factor: 7.396

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.